MYC and prostate carcinoma: Importantly, forced expression of stabilized MYC (MYCT58A) rescued NE transformation in prostate cancer models following treatment with a CDC7 inhibitor [57], implicating MYC as a key downstream effector of CDC7 during NE transformation.